Teraflex Hondrocrem Forte, cream for acute pain in joints, 100 g, Bayer

Dosage form

Cream from light yellow with a greenish tint to yellow with a greenish tint with the smell of dimethyl sulfoxide.

Structure

Active ingredients: chondroitin sodium sulfate - 50 mg, meloxicam - 10 mg.

Excipients: dimethyl sulfoxide - 100 mg, propylene glycol - 100 mg, macrogol cetostearate - 12 mg, cetostearyl alcohol [cetyl alcohol not more than 60%, stearyl alcohol not less than 40%] - 42 mg, liquid paraffin - 100 mg, petroleum jelly - 80 mg , imidourea - 3 mg, sodium disulfite - 0.5 mg, water up to 1.00 g

Special conditions

The drug should be applied only to intact skin, avoiding contact with open wounds.

Avoid contact with the eyes and mucous membranes.

You should consult your doctor before using Teraflex® Hondrocrem Forte together with other non-steroidal anti-inflammatory drugs, and if you need to use the drug for more than 2 weeks.

Influence on the ability to drive vehicles and use mechanisms

The drug does not cause a sedative effect, psychomotor disorders and does not affect the patient's ability to engage in potentially hazardous activities that require increased attention and speed of mental and motor reactions.

Drug interactions

Cases of interaction or incompatibility with other drugs have not been described.

Pharmacodynamics

Teraflex® Chondrocrem Forte has a combined effect: it slows down the progression of osteoarthritis and osteochondrosis, has an analgesic effect, increases the range of motion of the joints (in the area of ​​applying the cream), has an anti-inflammatory effect, and reduces joint swelling. Thanks to the optimal combination of the components of the cream, there is a mutual strengthening of their analgesic and anti-inflammatory effects.

Chondroitin sulfate is a high molecular weight mucopolysaccharide that is a natural component of cartilage tissue. Chondroitin sulfate improves phosphorus-calcium metabolism in cartilage tissue, inhibits enzymes that cause damage to cartilage tissue, inhibits degeneration (destruction) of cartilage tissue, stimulates the synthesis of glycosaminoglycans, promotes regeneration (restoration) of cartilaginous surfaces of joints, accelerates the processes of their repair, prevents the collapse of connective tissue ... This results in less pain and increased mobility in the affected joints.

Meloxicam is a non-steroidal anti-inflammatory drug that has anti-inflammatory, analgesic effects.

Meloxicam selectively inhibits cyclooxygenase 2, disrupts the metabolism of arachidonic acid, and reduces the amount of prostaglandins (mediators of pain and inflammation) in the focus of inflammation.

Meloxicam is a chondroneutral drug that does not adversely affect cartilage tissue, does not affect proteoglycan synthesis by articular cartilage chondrocytes.

Indications

The drug is recommended for use in the complex therapy of degenerative-dystrophic diseases of the musculoskeletal system: osteoarthritis, osteochondrosis of the spine

other joint diseases accompanied by pain syndrome.

Contraindications

Hypersensitivity to the components of the drug (as well as to other non-steroidal anti-inflammatory drugs), violation of the integrity of the skin in the places of intended application, children's age (up to 12 years).

Carefully

In case of impaired renal and liver function, with pronounced pathology of the gastrointestinal tract (peptic ulcer in the acute phase), with severe pathology of the blood system, old age.

Application during pregnancy and lactation

The use of the drug is contraindicated during pregnancy and lactation.

Overdose

Extremely low systemic absorption of the active components of the drug when applied externally makes an overdose almost impossible.

Side effects

Allergic skin reactions are possible (itching, redness, skin rash).

If any side effects appear, you must stop using the cream and consult a doctor.

INN / Active ingredient

Meloxicam + Chondroitin Sulfate

Dosage

1% + 5% x 100g

Indications

The drug is recommended for use in the complex therapy of degenerative-dystrophic diseases of the musculoskeletal system: osteoarthritis, osteochondrosis of the spine

other joint diseases accompanied by pain syndrome.

Contraindications

Hypersensitivity to the components of the drug (as well as to other non-steroidal anti-inflammatory drugs), violation of the integrity of the skin in the places of intended application, children's age (up to 12 years).

Carefully:

In case of impaired renal and liver function, with pronounced pathology of the gastrointestinal tract (peptic ulcer in the acute phase), with severe pathology of the blood system, old age.

Specifications

Item weight, g

one hundred

Package quantity, pcs

one

Scope of the medicinal product

Musculoskeletal system

Release form

Cream

Vacation conditions

Without recipe

Manufacturer country

Russia

A type

Medicine

Brand name

Teraflex

Type of consumer packaging

Pack of cardboard

Dosage form

Cream for external use

Pharmaco-therapeutic group

Tissue repair stimulant + NSAIDs

Anatomical and therapeutic characteristics

M02AX10 Other preparations

Expiration date in days

730

Primary packaging type

Tuba

The amount of the dosage form in the primary package

100 g

Drug action

Pain reliever

Package weight, g

one hundred

Category

:

Joints

,

Treatment of diseases of the musculoskeletal system

,

Synovial fluid

,

Bone metabolism

Information on technical characteristics, delivery set, country of manufacture